drug discovery, done right
small molecules, global reach
What We Do
We are experts in the research and production of small molecules for the pharmaceutical industry. We also have a 40-year legacy of research and development, the most promising of which forms our drug discovery pipeline.
Our Mission
Changing the face of disease through the accelerated advancement of our pipeline
Press Releases
Edmonton’s General Intermediates of Canada Inc. (GIC) announced today that they have successfully completed a research project related to a key starting API material for a global ...
Edmonton’s General Intermediates of Canada Inc. announced today that they have developed a unique process for making specialized bio-molecules for pharmaceutical fermenters, producing them in a certified, bio-safe manner. These ...
- Our mission is to change the face of disease through the accelerated development of our pipeline.
Learn more on ou… https://t.co/U8Usivq1VL
13 Oct 2017 - The immunotherapy safety assessment case will last for about a year.
https://t.co/dpAvQtzYvO
12 Oct 2017
